Search results
Moderna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy?
Motley Fool via Yahoo Finance· 2 hours agoThat'd be a big green flag for the stock, and in due time, it might become a competitive advantage...
Wealthspire Advisors LLC Has $301,000 Stock Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 8 hours agoThe institutional investor owned 3,028 shares of the company’s stock after selling 261 shares during the quarter. Wealthspire Advisors LLC’s holdings in Moderna< ...
Moderna Tumbles After The FDA Throws A Curveball On Its Second Product
Investor's Business Daily· 2 days agoModerna stock toppled Friday after the Food and Drug Administration delayed an approval decision on...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 4 days agoModerna stock broke out for the first time in over a year on May 2 after the biotech company notched...
Moderna director Noubar Afeyan sells over $1.8m in company stock By Investing.com
Investing.com· 2 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has recently sold a significant amount of...
If You'd Invested $1,000 in Moderna Stock 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 3 days agoShares nearly quintupled in calendar 2020, and ultimately rallied nearly 500% from 2019's low to...
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 3 days ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
Positive week for Moderna, Inc. (NASDAQ:MRNA) institutional investors who lost 6.8% over the past...
Simply Wall St. via Yahoo Finance· 3 days agoKey Insights Significantly high institutional ownership implies Moderna's stock price is sensitive...
Moderna’s mRNA dreams meet reality with first post-COVID shot - The Boston Globe
The Boston Globe· 3 days agoModerna’s stock dropped 45 percent last year, making it the worst-performing large biotech in the...
Moderna says FDA will not complete review of RSV vaccine by May 12 deadline
Market Watch· 2 days agoModerna Inc.’s stock fell 2.6% Friday, after the company said the Food and Drug Administration will...